23rd International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents

摘要 一年一度的卡波西肉瘤疱疹病毒和相关药物国际会议将 将研究致癌人类疱疹病毒的研究人员和临床医生聚集在一起， 卡波西肉瘤疱疹病毒(KSHV)和其他密切相关的病原体。KSHV是 卡波西肉瘤(KS)的病因学因素，它仍然是 非洲，特别是艾滋病毒-1感染者。这些会议的目标是一致的 NIH、NCI、NIAID和NIDCR的使命声明，即推进和促进 与人类癌症和其他疾病有关的感染研究的速度，包括 在艾滋病毒-艾滋病的背景下。KSHV主要会议将在坦桑尼亚的达累斯萨拉姆举行， 从2023年6月19日下午到6月22日。再加一天，6月23日， 培训研讨会，以吸引知名研究人员和受训人员、临床医生和基础 研究人员，在翻译研究项目上进行互动和发展合作。这个 会议的大部分费用将来自以下机构支付的注册费： 会议与会者和主办机构、基金会和制药公司的贡献 和生物技术公司。KSHV会议的主要焦点是生物 致癌疱疹病毒和相关的人类疾病，特别强调病毒 致病机制，病毒潜伏和重新激活，病毒基因表达和复制，宿主 对感染的反应，流行病学，疫苗开发，治疗干预，临床 和翻译研究。除了KSHV，与疱疹病毒SAIMIRI(HVS)相关的研究， 将介绍小鼠疱疹病毒-68(MHV-68)和恒河猴流感病毒(RRV)。这 行政补助申请申请拨款以补充R13奖励 (7R13CA250288)本应于2020年举行的会议收到。这个 推迟到2023年的原因是新冠肺炎。之所以需要补充，是因为 将需要奖励金额(5,000美元)来弥补计划中不断上升的通胀成本 注册费不能涵盖的会议地点。所要求的补充资料 资金将用于减少会议登记和未清偿的部分旅费 博士后和博士后实习生，历史上代表性不足的少数民族，以及来自 低收入和中等收入国家，特别是研究致癌DNA的非洲国家 病毒以及与这些病毒相关的癌症。

ABSTRACT The annual International Conference on Kaposi’s Sarcoma Herpesvirus and Related Agents will bring together researchers and clinicians working on the oncogenic human herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV), and other closely related pathogens. KSHV is the etiology agent of Kaposi’s sarcoma (KS), which is still one of the most prevalent cancers in Africa, especially in HIV-1 infected individuals. The goals of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to advance and promote the pace of research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The main KSHV conference will be held in Dar es Salaam, Tanzania, from the afternoon of June 19 through June 22, 2023. With an additional day, June 23, for a training workshop to engage both established researchers and trainees, clinicians and basic researchers, to interact and develop collaborations on translational research projects. The majority of the costs for the conference will be raised from registration fees paid by the conference attendees and contributions from host institutions, foundations, and pharmaceutical and biotechnology companies. The major focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, therapeutic intervention, clinical and translational research. In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. This administrative supplement grant application requests funds to supplement the R13 award (7R13CA250288) received for the conference which was supposed to be held in 2020. The reason for the delay to 2023 was due to COVID-19. The supplement is needed because of the awarded amount ($5,000) will be needed to cover the rising inflation cost of the planned conference site which cannot be covered by the registration fees. The requested supplement funds will be used to reduce the conference registration and partial travel costs for outstanding pre- and post-doctoral trainees, historically under-represented minorities, and scientists from lower- and middle-income countries, especially those from Africa who study oncogenic DNA viruses and the cancers associating with these viruses.